B.C.’s Stemcell Technologies feels the squeeze as U.S. research funding cuts, tariffs hit business

One of Canada’s largest life sciences companies, Stemcell Technologies Canada Inc., was already contending with tough conditions in the drug development market it serves before Donald Trump was re-elected as U.S. president last fall. Now, the Vancouver maker of media and instruments used in drug…